ADACEL-POLIO

This brand name is authorized in Brazil, Canada, Hong Kong SAR China, New Zealand, Nigeria, Poland, Romania, Singapore.

Active ingredients

The drug ADACEL-POLIO contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Tetanus toxoid UNII `K3W1N8YP13` - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Tetanus toxoid
`2`	Diphtheria toxoid UNII `IRH51QN26H` - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Diphtheria toxoid
`3`	Pertussis toxoid UNII `63GD90PP8X` - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
	Read more about Pertussis, purified antigen
`4`	Pertussis filamentous hemagglutinin UNII `8C367IY4EY` - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Pertussis filamentous hemagglutinin
`5`	Pertactin UNII `63GD90PP8X` - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
	Read more about Pertussis, purified antigen
`6`	Pertussis fimbriae types 2 and 3 UNII `1O0600285A` - BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
	Read more about Pertussis, purified antigen
`7`	Polio virus type 2 (MEF 1) UNII `23JE9KDF4R` - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 2
`8`	Polio virus type 1 (Mahoney) UNII `0LVY784C09` - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 1
`9`	Polio virus type 3 (Saukett) UNII `459ROM8M9M` - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 3

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07CA02	Diphtheria-pertussis-poliomyelitis-tetanus	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720040062417
CA	Health Products and Food Branch	02352044
HK	Department of Health Drug Office	56579
NG	Registered Drug Product Database	A6-100058
Switch country to Nigeria in order to find specific presentations of ADACEL-POLIO
NZ	Medicines and Medical Devices Safety Authority	12417
PL	Rejestru Produktów Leczniczych	100424777
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67254001, W67254002, W67254003, W67254004, W67254005, W67254006, W67254007
SG	Health Sciences Authority	15479P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.